Lucas Arruda

Company: CuraCell

Job title: Chief Scientific Officer

Seminars:

Reverse Engineering Clinical Success: Leveraging Sequencing Data & In Vitro Models to Decode TIL Therapy Mechanisms 9:00 am

Providing an overview of CuraCell’s strategy to work backward from clinical outcomes of their TIL therapy Utilising TCR sequencing and advanced omics data to uncover the mechanisms of TIL therapy Applying findings to enhance in vitro strategies and refine therapeutic protocolsRead more

day: Conference Day Two